NYSEMKT: AIM
Aim Immunotech Inc Stock Ownership - Who owns Aim Immunotech?

Insider buying vs selling

Have Aim Immunotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas K. EquelsCEO;Pres2026-11-1039,000$0.14
$5.38kBuy
Thomas K. EquelsCEO;Pres2026-11-0931,298$0.16
$5.07kBuy
Thomas K. EquelsCEO;Pres2026-11-0620,299$0.16
$3.17kBuy
Thomas K. EquelsCEO;Pres2026-11-0612,751$0.16
$2.01kBuy
Thomas K. EquelsCEO;Pres2026-10-2331,675$0.16
$5.07kBuy
Thomas K. EquelsCEO;Pres2026-10-2231,250$0.16
$5.09kBuy
Thomas K. EquelsCEO;Pres2026-09-1724,000$0.21
$4.99kBuy
Thomas K. EquelsCEO;Pres2026-09-1611,000$0.21
$2.31kBuy
Thomas K. EquelsCEO;Pres2026-09-1522,000$0.22
$4.86kBuy
Thomas K. EquelsCEO;Pres2026-09-145,900$0.22
$1.29kBuy

1 of 2

AIM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AIM insiders and whales buy or sell their stock.

AIM Shareholders

What type of owners hold Aim Immunotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ted D. Kellner15.68%4,774,709$706.66kInsider
William A. Carter6.95%2,116,170$313.19kInsider
Iraj Eqhbal Kiani2.07%630,886$93.37kInsider
William M. 1. Mitchell1.72%522,103$77.27kInsider
Peter W. Rodino Iii1.32%401,762$59.46kInsider
Stewart Appelrouth1.28%388,729$57.53kInsider
Thomas K. Equels1.01%306,095$45.30kInsider
Nancy Bryan0.96%291,882$43.20kInsider
Steven D. Spence0.69%209,410$30.99kInsider
Russel J. Lander0.68%207,983$30.78kInsider

1 of 3

AIM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AIM0.00%34.18%Net BuyingNet Buying
SNTI0.02%81.94%
ICU0.00%100.00%Net BuyingNet Buying
XTLB0.00%11.97%
CELZ0.00%13.79%

Aim Immunotech Stock Ownership FAQ

Who owns Aim Immunotech?

Aim Immunotech (NYSEMKT: AIM) is owned by 0.00% institutional shareholders, 34.18% Aim Immunotech insiders, and 65.82% retail investors. Ted D. Kellner is the largest individual Aim Immunotech shareholder, owning 4.77M shares representing 15.68% of the company. Ted D. Kellner's Aim Immunotech shares are currently valued at $711.43k.

If you're new to stock investing, here's how to buy Aim Immunotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.